Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine add-on to antipsychotics for sleep quality in schizophrenia
IRCT20260625069944N1Phase 2Recruiting
- Sponsor
- Arak University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of memantine in schizophrenia, sponsored by Arak University of Medical Sciences. Started Jun 2026; status: recruiting.
02
Drugs
memantine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT20260625069944N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260625069944N1.